Analysis of contemporary HIV/AIDS health care costs in Germany-Reference-Cited by-同舟云学术

Analysis of contemporary HIV/AIDS health care costs in Germany

Published:2016-06 Issue:26 Volume:95 Page:e3961
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Treskova Marina,Kuhlmann Alexander,Bogner Johannes,Hower Martin,Heiken Hans,Stellbrink Hans-Jürgen,Mahlich Jörg,Schulenburg Johann-Matthias Graf von der,Stoll Matthias

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference31 articles.

1. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population;Jaggy;Lancet,2003

2. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada;Samji;PLoS One,2013

3. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America;Helleberg;AIDS,2015

4. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel;Günthard;J Am Med Associat,2014

5. Contemporary costs of HIV healthcare in the HAART era;Gebo;AIDS,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial;Swiss Medical Weekly;2024-04-15

2. Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019;BMC Health Services Research;2022-01-13

3. What are the drivers of high-cost HIV patients?;International Journal of STD & AIDS;2021-05-19

4. Estimation of Health-State Utility Values and Factors Driving Health-Related Quality of Life in People Living with HIV and AIDS and Receiving cART in Germany: Baseline Analysis of a Cohort Study;Applied Research in Quality of Life;2021-03-30

5. Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study;Value in Health;2020-10